These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8555981)

  • 1. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls.
    Anseloni VZ; Motta V; Lima G; Brandão ML
    Braz J Med Biol Res; 1995 May; 28(5):597-601. PubMed ID: 8555981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the rat exploratory behavior in the elevated plus-maze with Markov chains.
    Tejada J; Bosco GG; Morato S; Roque AC
    J Neurosci Methods; 2010 Nov; 193(2):288-95. PubMed ID: 20869398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher detection sensitivity of anxiolytic effects of diazepam by ledge-free open arm with opaque walled closed arm elevated plus maze in male rats.
    Horii Y; Kawaguchi M
    Behav Brain Res; 2015 Nov; 294():131-40. PubMed ID: 26241172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
    Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
    Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethopharmacological analysis of rat behavior on the elevated plus-maze.
    Cruz AP; Frei F; Graeff FG
    Pharmacol Biochem Behav; 1994 Sep; 49(1):171-6. PubMed ID: 7816869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze.
    Anseloni VZ; Brandão ML
    Behav Pharmacol; 1997 Nov; 8(6-7):533-40. PubMed ID: 9832967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial.
    Ramos A; Pereira E; Martins GC; Wehrmeister TD; Izídio GS
    Behav Brain Res; 2008 Nov; 193(2):277-88. PubMed ID: 18590774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of pentylenetetrazol, chlordiazepoxide and caffeine in rats tested in the elevated plus-maze depend on the experimental illumination.
    Garcia AM; Cardenas FP; Morato S
    Behav Brain Res; 2011 Feb; 217(1):171-7. PubMed ID: 20933019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
    Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
    Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze.
    Bertoglio LJ; Carobrez AP
    Pharmacol Biochem Behav; 2002 May; 72(1-2):449-55. PubMed ID: 11900819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.
    Pellow S; Chopin P; File SE; Briley M
    J Neurosci Methods; 1985 Aug; 14(3):149-67. PubMed ID: 2864480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the elevated plus-maze test with opaque or transparent walls in the detection of mouse strain differences and the anxiolytic effects of diazepam.
    Hagenbuch N; Feldon J; Yee BK
    Behav Pharmacol; 2006 Feb; 17(1):31-41. PubMed ID: 16377961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of (S)-3,5-DHPG on learning, exploratory activity and anxiety in rats with experimental hypoxia.
    Nadlewska A; Car H; Oksztel R; Wiśniewski K
    Pol J Pharmacol; 2002; 54(1):11-8. PubMed ID: 12020039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational model for exploratory activity of rats with different anxiety levels in elevated plus-maze.
    Costa AA; Morato S; Roque AC; Tinós R
    J Neurosci Methods; 2014 Oct; 236():44-50. PubMed ID: 25128721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of rat behavior in the elevated plus-maze using a directed graph.
    Tejada J; Bosco GG; Morato S; Roque AC
    J Neurosci Methods; 2009 Nov; 184(2):251-5. PubMed ID: 19699234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
    Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
    Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1.
    Dal-Cól ML; Pereira LO; Rosa VP; Calixto AV; Carobrez AP; Faria MS
    Pharmacol Biochem Behav; 2003 Jan; 74(2):395-400. PubMed ID: 12479960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.